GS-9667

• Description:

  GS-9667 (CVT 3619), a novel N6-5'-substituted adenosine analog, is a selective, partial agonist of the A1 adenosine receptor (A1AdoR) . GS-9667 binds to adipocyte membranes with high (KH=14 nM) and low (KL=5.4 μM) affinities. GS-9667 reduces cyclic AMP content and release of nonesterified fatty acids from epididymal adipocytes with IC50 values of 6 nM and 44 nM, respectively. GS-9667 inhibits lipolysis and has the potential for Type 2 diabetes (T2DM) and dyslipidemia via lowering of free fatty acids (FFA) [1][2].

• Product Name Alternative:

  CVT 3619

• UNSPSC:

  12352005

• Target:

  Adenosine Receptor

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein

• Applications:

  Metabolism-sugar/lipid metabolism

• Field of Research:

  Metabolic Disease; Cardiovascular Disease

• Assay Protocol:

  https://www.medchemexpress.com/gs-9667.html

• Purity:

  98.08

• Solubility:

  DMSO : 125 mg/mL (ultrasonic)

• Smiles:

  O[C@H]1[C@@H] (O[C@@H] ([C@H]1O) CSC2=C (C=CC=C2) F) N3C4=NC=NC (N[C@H]5[C@@H] (CCC5) O) =C4N=C3

• Molecular Formula:

  C21H24FN5O4S

• Molecular Weight:

  461.51

• References & Citations:

  [1]Marjan Fatholahi, et al. A novel partial agonist of the A (1) -adenosine receptor and evidence of receptor homogeneity in adipocytes. J Pharmacol Exp Ther. 2006 May;317 (2) :676-84. |[2]Peter M Staehr, et al. Reduction of free fatty acids, safety, and pharmacokinetics of oral GS-9667, an A (1) adenosine receptor partial agonist. J Clin Pharmacol. 2013 Apr;53 (4) :385-92.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -20°C, 3 years (Powder)

• Scientific Category:

  Reference compound1

• Clinical Information:

  Phase 1

• CAS Number:

  618380-90-8